TY - JOUR
T1 - Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer
AU - Masetti, Michela
AU - Carriero, Roberta
AU - Portale, Federica
AU - Marelli, Giulia
AU - Morina, Nicoló
AU - Pandini, Marta
AU - Iovino, Marta
AU - Partini, Bianca
AU - Erreni, Marco
AU - Ponzetta, Andrea
AU - Magrini, Elena
AU - Colombo, Piergiuseppe
AU - Elefante, Grazia
AU - Simone Colombo, Federico
AU - den Haan, Joke M.M.
AU - Peano, Clelia
AU - Cibella, Javier
AU - Termanini, Alberto
AU - Kunderfranco, Paolo
AU - Brummelman, Jolanda
AU - Chung, Matthew Wai Heng
AU - Lazzeri, Massimo
AU - Hurle, Rodolfo
AU - Casale, Paolo
AU - Lugli, Enrico
AU - DePinho, Ronald A.
AU - Mukhopadhyay, Subhankar
AU - Gordon, Siamon
AU - Di Mitri, Diletta
N1 - Funding Information:
This work was supported by Associazione Italiana per la Ri-cerca sul Cancro (AIRC Start up ID 19141 to D. Di Mitri) and Minsal (Gr-2016-02363531 to D. Di Mitri). D. Di Mitri received funds from AIRC 5x1000 2019-ID 22757. M. Masetti is supported by a fellowship from Fondazione Umberto Veronesi. G. Marelli is supported by a fellowship from Associazione Italiana per la Ri-cerca sul Cancro (ID 22588) . E. Lugli is supported by Associa-zione Italiana per la Ricerca sul Cancro (AIRC IG 2017 – ID 20676). J. Brummelman is a recipient of the Associazione Italiana per la Ricerca sul Cancro “Fondo di beneficenza Intesa San Paolo” fellowship. Purchase of the BD FACSymphony A5 has been defrayed in part by Italian Ministry of Health (agreement 82/2015).
Publisher Copyright:
© 2021 Masetti et al.
PY - 2021/12/17
Y1 - 2021/12/17
N2 - Tumor-associated macrophages (TAMs) are correlated with the progression of prostatic adenocarcinoma (PCa). The mechanistic basis of this correlation and therapeutic strategies to target TAMs in PCa remain poorly defined. Here, single-cell RNA sequencing was used to profile the transcriptional landscape of TAMs in human PCa, leading to identification of a subset of macrophages characterized by dysregulation in transcriptional pathways associated with lipid metabolism. This subset of TAMs correlates positively with PCa progression and shorter disease-free survival and is characterized by an accumulation of lipids that is dependent on Marco. Mechanistically, cancer cell-derived IL-1β enhances Marco expression on macrophages, and reciprocally, cancer cell migration is promoted by CCL6 released by lipid-loaded TAMs.Moreover, administration of a highfat diet to tumor-bearing mice raises the abundance of lipid-loaded TAMs. Finally, targeting lipid accumulation by Marco blockade hinders tumor growth and invasiveness and improves the efficacy of chemotherapy in models of PCa, pointing to combinatorial strategies that may influence patient outcomes.
AB - Tumor-associated macrophages (TAMs) are correlated with the progression of prostatic adenocarcinoma (PCa). The mechanistic basis of this correlation and therapeutic strategies to target TAMs in PCa remain poorly defined. Here, single-cell RNA sequencing was used to profile the transcriptional landscape of TAMs in human PCa, leading to identification of a subset of macrophages characterized by dysregulation in transcriptional pathways associated with lipid metabolism. This subset of TAMs correlates positively with PCa progression and shorter disease-free survival and is characterized by an accumulation of lipids that is dependent on Marco. Mechanistically, cancer cell-derived IL-1β enhances Marco expression on macrophages, and reciprocally, cancer cell migration is promoted by CCL6 released by lipid-loaded TAMs.Moreover, administration of a highfat diet to tumor-bearing mice raises the abundance of lipid-loaded TAMs. Finally, targeting lipid accumulation by Marco blockade hinders tumor growth and invasiveness and improves the efficacy of chemotherapy in models of PCa, pointing to combinatorial strategies that may influence patient outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85122669745&partnerID=8YFLogxK
U2 - 10.1084/jem.20210564
DO - 10.1084/jem.20210564
M3 - Article
C2 - 34919143
AN - SCOPUS:85122669745
SN - 0022-1007
VL - 219
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 2
M1 - e20210564
ER -